TLR4 and fatty liver disease: The expression of TLR4 increased in hepatic steatosis individuals and is associated with raising serum LPS levels and intestinal barrier disruption [66], suggesting that the LPS/TLR4 pathway is one of the major mechanisms acting on the gut–liver axis.